missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ West Nile Virus Envelope Synthetic Peptide
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
West Nile Virus Envelope Synthetic Peptide, PEP-0222, from Invitrogen.
West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation.
Specifications
Specifications
| Species | Virus |
| Purification Method | purified |
| Common Name | West Nile Virus Envelope |
| Concentration | 200 μg/mL |
| Content And Storage | -20°C |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For Use With (Application) | Blocking Assay, Control |
| Lyophilized | No |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction